Search research articles
Contact Us
Filters
Showing results (181-190 of 302) with videos related to
Page
of 31
Sort By:
BMJ Open
|
April 12, 2017
Study protocol for a natural experiment in a lower socioeconomic area to examine the health-related effects of refurbishment to parks including built-shade (ShadePlus)
S J Dobbinson, J Veitch, J Salmon, et al.
Breast Cancer Research : BCR
|
March 16, 2001
Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system
J Zujewski, A Vaughn-Cooke, K C Flanders, et al.
The Journal of Clinical Investigation
|
December 1, 1990
Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution
L M Wakefield, T S Winokur, R S Hollands, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1986
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes
J H Kehrl, A B Roberts, L M Wakefield, et al.
Global Pediatric Health
|
July 18, 2019
"SPORTS ARE FUN": A Guide for the Discussion of Sport-Related Films
Robert P Olympia, Christy Lucas, Vignesh Doraiswamy, et al.
Journal of Cellular Physiology
|
May 1, 1994
Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprotease genes independent of TGF-beta
R T Ballock, A Heydemann, L M Wakefield, et al.
Developmental Biology
|
August 1, 1993
TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases
R T Ballock, A Heydemann, L M Wakefield, et al.
Oncotarget
|
May 21, 2016
Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium
Kathleen C Flanders, Yu-An Yang, Michelle Herrmann, et al.
The Journal of Clinical Investigation
|
October 3, 2003
TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
Binwu Tang, Mary Vu, Timberly Booker, et al.
Cell
|
February 13, 1987
Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells
C Knabbe, M E Lippman, L M Wakefield, et al.
Page
of 31
Search research articles
Search
Showing results (181-190 of 302) with videos related to
Sort By:
Page
of 31
BMJ Open
|
April 12, 2017
Study protocol for a natural experiment in a lower socioeconomic area to examine the health-related effects of refurbishment to parks including built-shade (ShadePlus)
S J Dobbinson, J Veitch, J Salmon, et al.
Breast Cancer Research : BCR
|
March 16, 2001
Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system
J Zujewski, A Vaughn-Cooke, K C Flanders, et al.
The Journal of Clinical Investigation
|
December 1, 1990
Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution
L M Wakefield, T S Winokur, R S Hollands, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1986
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes
J H Kehrl, A B Roberts, L M Wakefield, et al.
Global Pediatric Health
|
July 18, 2019
"SPORTS ARE FUN": A Guide for the Discussion of Sport-Related Films
Robert P Olympia, Christy Lucas, Vignesh Doraiswamy, et al.
Journal of Cellular Physiology
|
May 1, 1994
Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprotease genes independent of TGF-beta
R T Ballock, A Heydemann, L M Wakefield, et al.
Developmental Biology
|
August 1, 1993
TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases
R T Ballock, A Heydemann, L M Wakefield, et al.
Oncotarget
|
May 21, 2016
Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium
Kathleen C Flanders, Yu-An Yang, Michelle Herrmann, et al.
The Journal of Clinical Investigation
|
October 3, 2003
TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
Binwu Tang, Mary Vu, Timberly Booker, et al.
Cell
|
February 13, 1987
Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells
C Knabbe, M E Lippman, L M Wakefield, et al.
Page
of 31